[PHARMA] YoY Cumulative Quarter Result on 31-Mar-2010 [#1]

Announcement Date
26-May-2010
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2010
Quarter
31-Mar-2010 [#1]
Profit Trend
QoQ- -84.54%
YoY- -35.91%
Quarter Report
View:
Show?
Cumulative Result
31/03/13 31/03/12 31/03/11 31/03/10 31/03/09 31/03/08 31/03/07 CAGR
Revenue 500,339 446,745 385,328 317,560 313,716 309,650 256,235 11.78%
PBT 36,924 42,955 21,792 12,431 20,184 27,374 10,230 23.82%
Tax -11,771 -13,894 -6,193 -3,122 -5,491 -8,392 -3,737 21.05%
NP 25,153 29,061 15,599 9,309 14,693 18,982 6,493 25.29%
-
NP to SH 24,771 28,685 15,484 9,307 14,522 18,545 6,069 26.38%
-
Tax Rate 31.88% 32.35% 28.42% 25.11% 27.20% 30.66% 36.53% -
Total Cost 475,186 417,684 369,729 308,251 299,023 290,668 249,742 11.30%
-
Net Worth 484,829 474,161 437,661 439,675 402,378 367,905 321,111 7.10%
Dividend
31/03/13 31/03/12 31/03/11 31/03/10 31/03/09 31/03/08 31/03/07 CAGR
Div 8,825 8,824 - - - - - -
Div Payout % 35.63% 30.76% - - - - - -
Equity
31/03/13 31/03/12 31/03/11 31/03/10 31/03/09 31/03/08 31/03/07 CAGR
Net Worth 484,829 474,161 437,661 439,675 402,378 367,905 321,111 7.10%
NOSH 117,676 117,657 107,007 106,977 107,015 106,949 107,037 1.59%
Ratio Analysis
31/03/13 31/03/12 31/03/11 31/03/10 31/03/09 31/03/08 31/03/07 CAGR
NP Margin 5.03% 6.51% 4.05% 2.93% 4.68% 6.13% 2.53% -
ROE 5.11% 6.05% 3.54% 2.12% 3.61% 5.04% 1.89% -
Per Share
31/03/13 31/03/12 31/03/11 31/03/10 31/03/09 31/03/08 31/03/07 CAGR
RPS 425.18 379.70 360.09 296.85 293.15 289.53 239.39 10.03%
EPS 21.05 24.38 14.47 8.70 13.57 17.34 5.67 24.41%
DPS 7.50 7.50 0.00 0.00 0.00 0.00 0.00 -
NAPS 4.12 4.03 4.09 4.11 3.76 3.44 3.00 5.42%
Adjusted Per Share Value based on latest NOSH - 106,977
31/03/13 31/03/12 31/03/11 31/03/10 31/03/09 31/03/08 31/03/07 CAGR
RPS 34.72 31.00 26.74 22.03 21.77 21.48 17.78 11.78%
EPS 1.72 1.99 1.07 0.65 1.01 1.29 0.42 26.46%
DPS 0.61 0.61 0.00 0.00 0.00 0.00 0.00 -
NAPS 0.3364 0.329 0.3037 0.3051 0.2792 0.2553 0.2228 7.10%
Price Multiplier on Financial Quarter End Date
31/03/13 31/03/12 31/03/11 31/03/10 31/03/09 31/03/08 31/03/07 CAGR
Date 29/03/13 30/03/12 31/03/11 31/03/10 31/03/09 31/03/08 30/03/07 -
Price 8.26 5.90 5.73 4.27 3.45 2.95 3.55 -
P/RPS 1.94 1.55 1.59 1.44 1.18 1.02 1.48 4.60%
P/EPS 39.24 24.20 39.60 49.08 25.42 17.01 62.61 -7.48%
EY 2.55 4.13 2.53 2.04 3.93 5.88 1.60 8.07%
DY 0.91 1.27 0.00 0.00 0.00 0.00 0.00 -
P/NAPS 2.00 1.46 1.40 1.04 0.92 0.86 1.18 9.18%
Price Multiplier on Announcement Date
31/03/13 31/03/12 31/03/11 31/03/10 31/03/09 31/03/08 31/03/07 CAGR
Date 15/05/13 03/05/12 13/05/11 26/05/10 08/05/09 28/05/08 25/05/07 -
Price 9.26 5.90 5.05 4.71 3.82 3.45 3.45 -
P/RPS 2.18 1.55 1.40 1.59 1.30 1.19 1.44 7.14%
P/EPS 43.99 24.20 34.90 54.14 28.15 19.90 60.85 -5.25%
EY 2.27 4.13 2.87 1.85 3.55 5.03 1.64 5.56%
DY 0.81 1.27 0.00 0.00 0.00 0.00 0.00 -
P/NAPS 2.25 1.46 1.23 1.15 1.02 1.00 1.15 11.82%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ & YoY figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment